Did you know?
By shortening diagnosis time, the BD MGIT™ (Mycobacteria Growth Indicator Tube) system can help stop tuberculosis.

BD Diagnostics - Diagnostic Systems is a leading provider of reagents and instruments used for diagnosing a broad range of infectious diseases, healthcare-associated infections and cancer. In the clinical market we offer products and services with focus on TB, Sepsis, HAIs, Sexually Transmitted Diseases and Cervical Cancer abnormal cell screening tests. In the industrial market, Diagnostic Systems' products are used for the testing of sterile and non-sterile pharmaceuticals and medical devices, for environmental monitoring and to detect food pathogens. In both markets we are fully committed to the enhancement of laboratory efficiency. Learn more>>
<b>BD Innova</b><br>
We invite you to experience efficiency with the BD Innova<br>
BD Innova
We invite you to experience efficiency with the BD Innova

Learn more »

[spacer image]

Receive information on BD complete solutions
Receive information on BD complete solutions
Sign up Now »

[spacer image]


Learn More »




News & Events

[bullet] BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions »

[bullet] First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe. »

[bullet] BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System »

[bullet] BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System »

[bullet] BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians »

[bullet] BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System »

[bullet] New Amplified Molecular Tests Launched to Help Improve Diagnosis and Treatment of Herpes Patients »

[bullet] BACTEC™ User Group (BUG) 2010 Presentations »

[bullet] BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing »

[bullet] Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide »

[bullet] BD Announces European Launch of the BD MAX™ System for Molecular Diagnostics »

[bullet] BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor »

[bullet] BD Completes Acquisition of HandyLab, Inc. »

[bullet] Launch of BD MGIT™ TBc Identification Test in Africa and the European Union » »

[bullet] BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer »

[bullet] BD Adds Surveillance Capability to Infectious Disease Portfolio » »

[bullet] New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Microbiology Data Management System now Available Worldwide »

[bullet] BD GeneOhm™ Cdiff Assay CE Marked and Submitted for FDA Clearance »

 
Archive»